QTTB - Q32 Bio Inc.
IEX Last Trade
43.04
3.800 8.829%
Share volume: 236,506
Last Updated: Fri 30 Aug 2024 09:59:21 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$39.24
3.80
9.68%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-15 | 2022-11-10 | 2023-03-09 | 2023-05-11 | 2023-08-14 | 2023-11-14 | 2024-03-13 | 2024-05-09 | |
| Total revenue | 802.000 K | 802.000 K | 802.000 K | 802.000 K | 354.000 K | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 802.000 K | 802.000 K | 802.000 K | 802.000 K | 354.000 K | 0.000 | 0.000 | 0.000 | |
| 0.00% | 0.00% | 0.00% | -55.86% | -100.00% | nan% | nan% | |||
| Operating expenses | 29.109 M | 33.664 M | 35.296 M | 28.313 M | 31.170 M | 24.361 M | 9.414 M | 14.843 M | |
| Selling general and admin | 8.034 M | 7.810 M | 8.147 M | 8.325 M | 8.188 M | 6.842 M | 7.901 M | 5.002 M | |
| Research and development | 21.075 M | 25.854 M | 27.149 M | 19.988 M | 22.982 M | 17.519 M | 1.513 M | 9.841 M | |
| Total expenses | 29.109 M | 33.664 M | 35.296 M | 28.313 M | 31.170 M | 24.361 M | 9.414 M | 14.843 M | |
| 15.65% | 4.85% | -19.78% | 10.09% | -21.84% | -61.36% | 57.67% | |||
| Operating income | -28.307 M | -32.862 M | -34.494 M | -27.511 M | -30.816 M | -24.361 M | -9.414 M | -14.843 M | |
| Ebit | -28.307 M | -32.862 M | -34.494 M | -27.511 M | -30.816 M | -24.361 M | -9.414 M | -14.843 M | |
| Pretax income | -27.833 M | -31.593 M | -33.039 M | -26.042 M | -29.305 M | -29.578 M | -2.155 M | 1.205 M | |
| 13.51% | 4.58% | -21.18% | 12.53% | 0.93% | -92.71% | -155.92% | |||
| Income tax | -105.000 K | -46.000 K | -101.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -29.089 M | -33.726 M | -34.295 M | -28.844 M | -35.044 M | -32.954 M | -16.119 M | 1.029 M | |
| -15.94% | -1.69% | 15.89% | -21.49% | 5.96% | 51.09% | 106.38% | |||
| Net income | -29.089 M | -33.726 M | -34.295 M | -28.844 M | -35.044 M | -32.954 M | -16.119 M | 1.029 M | |
| -15.94% | -1.69% | 15.89% | -21.49% | 5.96% | 51.09% | 106.38% |